Kevin K. Roggin to Chemotherapy, Adjuvant
This is a "connection" page, showing publications Kevin K. Roggin has written about Chemotherapy, Adjuvant.
Connection Strength
0.553
-
Trends in the Use of Adjuvant Chemotherapy for High-Grade Truncal and Extremity Soft Tissue Sarcomas. J Surg Res. 2020 01; 245:577-586.
Score: 0.157
-
Assessing the Role of Neoadjuvant Chemotherapy in Primary High-Risk Truncal/Extremity Soft Tissue Sarcomas: An Analysis of the Multi-institutional U.S. Sarcoma Collaborative. Ann Surg Oncol. 2019 Oct; 26(11):3542-3549.
Score: 0.155
-
The role of radiation therapy and margin width in localized soft-tissue sarcoma: Analysis from the US Sarcoma Collaborative. J Surg Oncol. 2019 Sep; 120(3):325-331.
Score: 0.039
-
Perioperative chemotherapy is not associated with improved survival in high-grade truncal sarcoma. J Surg Res. 2018 11; 231:248-256.
Score: 0.036
-
The impact of changes in radiographic sarcopenia on overall survival in older adults undergoing different treatment pathways for pancreatic cancer. J Geriatr Oncol. 2018 07; 9(4):367-372.
Score: 0.035
-
Primary systemic therapy in resectable pancreatic ductal adenocarcinoma using mFOLFIRINOX: A pilot study. J Surg Oncol. 2018 Mar; 117(3):354-362.
Score: 0.034
-
Laparoscopic pancreaticoduodenectomy for adenocarcinoma provides short-term oncologic outcomes and long-term overall survival rates similar to those for open pancreaticoduodenectomy. Am J Surg. 2017 Mar; 213(3):512-515.
Score: 0.033
-
Neoadjuvant external beam radiation is associated with No benefit in overall survival for early stage pancreatic cancer. Am J Surg. 2017 Mar; 213(3):521-525.
Score: 0.032
-
Perioperative chemotherapy is associated with a survival advantage in early stage adenocarcinoma of the pancreatic head. Surgery. 2016 09; 160(3):714-24.
Score: 0.031